Nakhaie Shahrbanoo, Sharif Amin Sadat, Hosseini Shamsabadi Rozita, Otukesh Hasan, Hashemipour Maryam, Mohammadi Shahrzad
Pediatric Gastrointestinal Department, Aliasghar Hospital, Iran University of Medical Sciences, Tehran, Iran.
Department of Pediatric Nephrology, Iran University of Medical Sciences, Tehran, Iran.
Med J Islam Repub Iran. 2022 Feb 28;36:15. doi: 10.47176/mjiri.36.15. eCollection 2022.
Cystinosis is a multisystemic disease caused by the accumulation of cystine crystals in the kidney and many other organs. This disease most often involves children. Recent developments in the treatment procedures have improved the chance of patients surviving as long as puberty. This study discusses the importance of immediate diagnosis and early treatment of the disease with cystagon, which reduces gastrointestinal complications in such patients. This descriptive study was performed on 19 adult patients (over 18 years old) with cystinosis who were observed by nephrologists from medical universities throughout Iran. Gastrointestinal complications were studied in the patients. Data were analyzed using SPSS Version 22. The mean age of patients at the time of enrollment was 23.89 ± 5.06 years. Seventeen (89.4%) patients of this group had received renal replacement therapy (3 dialysis, 14 renal transplantation) due to end-stage renal disease and 2 (10.5%) of them were in stages 2 and 3 of chronic kidney disease. Three patients (15.7%) had hepatomegaly and splenomegaly; liver enzymes were normal in all patients. One patient (5.2%) had increased portal vein flow velocities, 2 of the patients (10.5%) underwent percutaneous endoscopic gastrostomy implantation due to severe dysphagia and eventually died. Most gastrointestinal symptoms in patients were nausea and abdominal pain. Early diagnosis and treatment with the proper dose of cystagon can increase life expectancy, reduce complications, and improve the patient's quality of life.
胱氨酸病是一种多系统疾病,由胱氨酸晶体在肾脏和许多其他器官中蓄积所致。这种疾病最常累及儿童。治疗方法的最新进展提高了患者存活至青春期的几率。本研究讨论了使用胱氨酸胺(Cystagon)对该疾病进行早期诊断和治疗的重要性,它可减少此类患者的胃肠道并发症。这项描述性研究对19例成年胱氨酸病患者(年龄超过18岁)进行,这些患者由伊朗各地医科大学的肾病学家进行观察。对患者的胃肠道并发症进行了研究。数据使用SPSS 22版进行分析。入组时患者的平均年龄为23.89±5.06岁。该组17例(89.4%)患者因终末期肾病接受了肾脏替代治疗(3例透析,14例肾移植),2例(10.5%)处于慢性肾脏病2期和3期。3例患者(15.7%)有肝肿大和脾肿大;所有患者的肝酶均正常。1例患者(5.2%)门静脉血流速度增加,2例患者(10.5%)因严重吞咽困难接受了经皮内镜下胃造口术植入,最终死亡。患者的大多数胃肠道症状为恶心和腹痛。用适当剂量的胱氨酸胺进行早期诊断和治疗可提高预期寿命、减少并发症并改善患者生活质量。